New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 29, 2017 – The FDA approved a revision to the indication for QVAR (beclomethasone dipropionate HFA). Information regarding asthma patients requiring oral corticosteroid therapy was removed.
Download PDF
Return to publications
